Indian Pharma Companies
Three key reasons why CLSA is bullish on pharma MNCs in India
New FDA warning letters show Indian drug makers' quality concerns persist
Indian pharmaceutical companies spread business to avoid regulatory ire
FDA observations on Telangana plant a fresh headache for Aurobindo Pharma
USFDA impact: DCGI asks states told to put antacids under scanner

S&P revises Glenmark outlook to 'negative' on weak operating performance
Dr Reddy's to Lupin, Indian pharma players get a leg up from domestic sales
China's new drug law may open door for Indian generic medicines: Report
300 fresh pharma unit applications up for approval in Gujarat: FDCA
Sun Pharma signs global licensing pact with CSIR-IICT for patents

Aurobindo Q1 profit up 39.5% at Rs 636 crore on strong revenue growth
India's new drug nods from US dip in Q1 due to increased scrutiny on firms
Pharma funds remain in poor health amid headwinds on compliance
What's bugging Indian, Chinese medicine companies making crucial heart drug
Charticle: How Jan Aushadhi stores are disrupting the Indian pharma market
Jan Aushadhi scheme may disrupt 20% of Indian pharma market sales: Report
Cold wave across US to bring big business for Indian drug companies
Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL
Warning letters to Indian pharma companies from US FDA declining: Study
Indian pharma sees traction in novel biologics